Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells (original) (raw)

• Paper
• Published: 01 April 1997
• C Asselin-Paturel2,
• F Bex1,
• J Bernard3,
• J Chehimi4,
• F Willems1,
• A Caignard2,
• P Berglund5,
• P Liljeström5,
• A Burny1 &
• …
• S Chouaib2

Gene Therapy volume 4, pages 367–374 (1997)Cite this article

• 505 Accesses
• 26 Citations
• 9 Altmetric
• Metrics details

Abstract

IL-12 can enhance the development of effective immune responses against tumors as well as against certain infectious agents. It is therefore a potential candidate for therapeutic use in cancer therapy and in the design of vaccines against several infectious diseases. Several studies have demonstrated that IL-12 could efficiently induce tumor regression in animal models. To investigate the antitumor effect of direct gene transfer of human IL-12 into tumors, human IL-12 p35 and p40 cDNAs were cloned into the Semliki Forest virus (SFV) vector pSFV1. In order to express the two subunits from the same vector, the p35 and the p40 cDNAs were cloned into pSFV1, each under the control of a subgenomic SFV promoter. Recombinant RNA produced by in vitro transcription of SFV-IL-12 construct, was packaged into SFV viral particles with the use of a non-packageable helper RNA. We show that human tumor cell lines infected in vitro and in vivo with recombinant SFV-IL-12 viral particles secrete high levels of biologically active heterodimeric p35/p40 IL-12, as demonstrated using ELISA and biological assays.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

Similar content being viewed by others

Author information

Authors and Affiliations

1. Université Libre de Bruxelles, Belgium
   J Zhang, F Bex, F Willems & A Burny
2. CJF 94-11 INSERM, Institut Gustave-Roussy, Villejuif, France
   C Asselin-Paturel, A Caignard & S Chouaib
3. Institut Jean-Godinot, Reims, France
   J Bernard
4. Children’s Hospital of Philadelphia, USA
   J Chehimi
5. Karolinska Institute, Huddinge, Sweden
   P Berglund & P Liljeström

Authors

1. J Zhang
   You can also search for this author inPubMed Google Scholar
2. C Asselin-Paturel
   You can also search for this author inPubMed Google Scholar
3. F Bex
   You can also search for this author inPubMed Google Scholar
4. J Bernard
   You can also search for this author inPubMed Google Scholar
5. J Chehimi
   You can also search for this author inPubMed Google Scholar
6. F Willems
   You can also search for this author inPubMed Google Scholar
7. A Caignard
   You can also search for this author inPubMed Google Scholar
8. P Berglund
   You can also search for this author inPubMed Google Scholar
9. P Liljeström
   You can also search for this author inPubMed Google Scholar
10. A Burny
    You can also search for this author inPubMed Google Scholar
11. S Chouaib
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Zhang, J., Asselin-Paturel, C., Bex, F. et al. Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells.Gene Ther 4, 367–374 (1997). https://doi.org/10.1038/sj.gt.3300409

Download citation

• Received: 05 November 1996
• Accepted: 08 January 1997
• Issue Date: 01 April 1997
• DOI: https://doi.org/10.1038/sj.gt.3300409

Keywords

This article is cited by